Dose Finding and Related Topics in Drug Development
Volume 3, Issue 3 (2025), pp. 209–211
Pub. online: 23 January 2026
Type: Editorial
Open Access
Open Access
Published
23 January 2026
23 January 2026
References
Han, L., Deng, Q., He, Z. and Yu, F. (2025). LiMAP-Curvature: A Simple Model-Free Approach for Analysing Dose-Finding Studies. The New England Journal of Statistics in Data Science 3(3) 265–271. https://doi.org/10.51387/25-NEJSDS90.
Hawila, R. and Wages, N. A. (2025). Shift Models for Dose-Finding in Ordered Groups with Late-Onset Toxicity. The New England Journal of Statistics in Data Science 3(3) 234–241. https://doi.org/10.51387/25-NEJSDS88.
Oron, A. P. and Flournoy, N. (2024). Up-and-Down: The Most Popular, Most Reliable, and Most Overlooked Dose-Finding Design. The New England Journal of Statistics in Data Science 3(3) 222–233. https://doi.org/10.51387/24-NEJSDS74.
Ting, N. (2025). Risks in Finding Doses for a New Drug. The New England Journal of Statistics in Data Science 3(3) 212–221. https://doi.org/10.51387/25-NEJSDS081.
Wang, Y., Chi, X. and Lin, R. (2025). Three-Outcome Dual-Criterion Randomized Phase II Clinical Trial Design. The New England Journal of Statistics in Data Science 3(3) 272–281. https://doi.org/10.51387/25-NEJSDS83.
Xiang, M., Ma, Y. and Li, Q. (2025). Two-Stage Design Sample Size Determination for Two Doses in Oncology Phase II Trials. The New England Journal of Statistics in Data Science 3(3) 253–264. https://doi.org/10.51387/25-NEJSDS80.
Zhou, W., MaWhinney, S., Anderson, P. and Kaizer, A. (2025). Bayesian Information Sharing and Interim Efficacy Monitoring for Equivalence Testing with an Application to Dose Proportionality Studies. The New England Journal of Statistics in Data Science 3(3) 242–252. https://doi.org/10.51387/25-NEJSDS95.
